SEARCH

SEARCH BY CITATION

References

  • 1
    Safadi BY, Marks JM, Ponsky JL. Percutaneous endoscopic gastrostomy. Gastrointest Clin N Am 1998; 8: 55168.
  • 2
    Rey JR, Axon A, Budzynska A, Kruse A, Nowak A. Guidelines of the European Society of Gastrointestinal Endoscopy. Antibiotic prophylaxis for gastrointestinal endoscopy. Endoscopy 1998; 30: 31824.
  • 3
    American Society for Gastrointestinal Endoscopy. Infection control during gastrointestinal endoscopy—guidelines for clinical application. Gastrointest Endosc 1999; 49: 83641.
  • 4
    British Society of Gastroenterology. Antibiotic Prophylaxis in Gastrointestinal Endoscopy, 2001. Quorn Selective Retro, Loughborough, Leicestershire.
  • 5
    Jain NK, Larson DE, Schroeder KW, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. Ann Intern Med 1987; 107: 8248.
  • 6
    Jonas SK, Neimark S, Panwalker AP. Effect of antibiotic prophylaxis in percutaneous endoscopic gastrostomy. Am J Gastroenterol 1985; 80: 43841.
  • 7
    Akkersdijk WL, Van Bergeijk JD, Van Egmond T, et al. Percutaneous endoscopic gastrostomy (PEG): Comparison of push and pull methods and evaluation of antibiotic prophylaxis. Endoscopy 1995; 27: 3136.
  • 8
    Preclik G, Grune S, Leser HG, et al. Prospective randomised double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. Br Med J 1999; 319: 8814.
  • 9
    Sturgis TM, Yancy W, Cole JC. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy. Am J Gastroenterol 1996; 91: 23014.
  • 10
    Gossner L, Keymling J, Hahn EG, Ell C. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomised clinical trial. Endoscopy 1999; 31: 11924.
  • 11
    Dormann AJ, Wigginghaus B, Risius H, et al. A single dose of ceftriaxone administered 30 minutes before percutaneous endoscopic gastrostomy significantly reduces local and systemic infective complications. Am J Gastroenterol 1999; 94: 32204.
    Direct Link:
  • 12
    Sharma VK & Howden CW. Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy. Am J Gastroenterol 2000; 95: 31336.
    Direct Link:
  • 13
    Deitel M, Bendago M, Spratt EH, Burul CJ. Percutaneous endoscopic gastrostomy by the ‘pull’ and ‘introducer’ methods. Can J Surg 1988; 31: 1024.
  • 14
    Pien ECT, Hume KE, Pien FD. Gastrostomy tube infections in a community hospital. Am J Infect Control 1996; 24: 3538.
  • 15
    Reacher MH, Shah A, Livermore DM, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. Br Med J 2000; 320: 2136.
  • 16
    Smith PW, Seip CW, Schaefer SC, Bell-Dixon C. Microbiologic survey of long-term care facilities. Am J Infect Control 2000; 28: 813.
  • 17
    Sanders DS & Carter MJ. Antibiotic prophylaxis after percutaneous endoscopic gastrostomy insertion. All encompassing study is needed. Br Med J 2000; 320: 870870 [letter].
  • 18
    Hull MA, Rawlings J, Murray FE, et al. Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy. Lancet 1993; 341: 86972.
  • 19
    Mohammed I & Jones BJM. Antibiotic prophylaxis after percutaneous endoscopic gastrostomy insertion. Widespread routine use of prophylactic antibiotics might predispose to increased risk of resistant organisms. Br Med J 2000; 320: 870870 [letter].
  • 20
    Ahmad I & Thomas GAO. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy insertion. A national survey of current practice in the United Kingdom. Gastroenterol Today 2000; 10: 1045.
  • 21
    Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998; 27: 54350.